There have been 31 recent insider transactions recorded for BioNTech SE (BNTX), including 0 buys and 0 sells.
Notable insiders with recent activity include Poetting Sierk, Tureci Ozlem, Hanekamp Annemarie. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — BNTX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2029-05-28 |
Poetting Sierk |
Chief Operating Officer |
Unknown |
8,838 |
- |
- |
- |
| 2029-05-28 |
Tureci Ozlem |
Chief Medical Officer |
Unknown |
9,306 |
- |
- |
- |
| 2029-05-28 |
Hanekamp Annemarie |
Chief Commercial Officer |
Unknown |
8,838 |
- |
- |
- |
| 2029-05-28 |
Ryan James Timothy Patrick |
See Remarks. |
Unknown |
8,838 |
- |
- |
- |
| 2029-05-28 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
18,747 |
- |
- |
- |
| 2029-05-27 |
Poetting Sierk |
Chief Operating Officer |
Unknown |
11,047 |
- |
- |
- |
| 2029-05-27 |
Tureci Ozlem |
Chief Medical Officer |
Unknown |
11,633 |
- |
- |
- |
| 2029-05-27 |
Hanekamp Annemarie |
Chief Commercial Officer |
Unknown |
11,047 |
- |
- |
- |
| 2029-05-27 |
Ryan James Timothy Patrick |
See Remarks. |
Unknown |
11,047 |
- |
- |
- |
| 2029-05-27 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
23,434 |
- |
- |
- |
| 2027-12-08 |
Ryan James Timothy Patrick |
See Remarks. |
Unknown |
750 |
- |
- |
- |
| 2027-05-22 |
Poetting Sierk |
Chief Operating Officer |
Unknown |
18,416 |
$113.94 |
$2.1M |
- |
| 2027-05-22 |
Tureci Ozlem |
Chief Medical Officer |
Unknown |
18,416 |
$113.94 |
$2.1M |
- |
| 2027-05-22 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
38,506 |
$113.94 |
$4.39M |
- |
| 2026-05-31 |
Poetting Sierk |
Chief Operating Officer |
Unknown |
14,664 |
$152.10 |
$2.23M |
- |
| 2026-05-31 |
Tureci Ozlem |
Chief Medical Officer |
Unknown |
14,664 |
$152.10 |
$2.23M |
- |
| 2026-05-31 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
19,997 |
$152.10 |
$3.04M |
- |
| 2026-03-18 |
Poetting Sierk |
Chief Operating Officer |
Unknown |
- |
- |
- |
1,638 |
| 2026-03-18 |
Jeggle Helmut Wolfgang |
Director |
Unknown |
- |
- |
- |
332,316 |
| 2026-03-18 |
Motschmann Michael |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Wandschneider Ulrich |
Director |
Unknown |
- |
- |
- |
1,927 |
| 2026-03-18 |
Ryan James Timothy Patrick |
See Remarks. |
Unknown |
- |
- |
- |
4,795 |
| 2026-03-18 |
Jimenez Kylie |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
- |
- |
- |
858,209 |
| 2026-03-18 |
Zapata Gomez Ramon |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Blackwood Nicola Claire |
Director |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Morawietz Anja |
Director |
Unknown |
- |
- |
- |
40 |
| 2026-03-18 |
Staudigl Rudolf |
Director |
Unknown |
- |
- |
- |
400 |
| 2025-05-12 |
Poetting Sierk |
Chief Operating Officer |
Unknown |
7,112 |
$185.23 |
$1.32M |
- |
| 2025-05-12 |
Tureci Ozlem |
Chief Medical Officer |
Unknown |
7,112 |
$185.23 |
$1.32M |
- |
| 2025-05-12 |
Sahin Ugur |
10 Percent Owner, Officer: Chief Executive Officer |
Unknown |
17,780 |
$185.23 |
$3.29M |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
